Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT00167219
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Juvenile Myelomonocytic Leukemia
Interventions
BIOLOGICAL:
Stem Cell Transplant
DRUG:
Preparative Regimen
Sponsor
Masonic Cancer Center, University of Minnesota